Contract award · 10 Mar 2021
Trastuzumab (Herceptin®) 600mg/5ml solution for Injection
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Trastuzumab (Herceptin®) 600mg/5ml solution for Injection” to Roche Products Ltd for £27.1m on 10 Mar 2021. Awarded without open competition.
No competition- Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
- Supplier
- Roche Products Ltd SME
- Value
- £27,141,272
- Contract date
- 10 Mar 2021
- Published
- 11 Mar 2021
- Procedure
- Negotiated without publication of a contract notice
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- Scotland
- Official notice
- 004908-2021 on Find a Tender
Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.
Description
The supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland.
About the supplier
- Roche Products Ltd: every public contract they have won.